 |
 |
 |
| |
Lack of Clinically Relevant Drug Interactions Between
Elvitegravir plus Ritonavir Boosted-Atazanavir and Telaprevir
|
| |
| |
Reported by Jules Levin
20th International AIDS Conference, July 20-25, 2014, Melbourne
JM Custodio, S Guo, EB Lawson, H Cao, A Silva, BP Kearney, and S Ramanathan
Gilead Sciences, Inc., Foster City, CA, USA







|
| |
|
 |
 |
|
|